Skip to main content
Clinical Trials/NCT07270107
NCT07270107
Completed
Not Applicable

Immersive Virtual Reality Versus Traditional Instruction for Teaching the Bobath Concept in Physiotherapy Education: A Randomized Controlled Trial

Kocaeli Sağlık ve Teknoloji Üniversitesi1 site in 1 country20 target enrollmentStarted: May 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Kocaeli Sağlık ve Teknoloji Üniversitesi
Enrollment
20
Locations
1
Primary Endpoint
Practical Performance Score (OSCE)

Overview

Brief Summary

This randomized controlled trial evaluated the effectiveness of immersive virtual reality (VR)-based instruction compared with traditional face-to-face teaching for delivering the Bobath concept in physiotherapy education. Third-year physiotherapy students were randomly assigned to either VR-based or conventional instruction and completed standardized theoretical and practical assessments immediately after training and again two weeks later. While both instructional methods resulted in comparable short-term learning outcomes, the VR group demonstrated superior retention of practical skills at follow-up. Findings suggest that immersive VR is a feasible and effective educational approach for enhancing motor skill learning in neurophysiological rehabilitation training.

Detailed Description

This two-arm, parallel-group, single-blind randomized controlled trial aims to investigate whether immersive virtual reality (VR)-based education can enhance learning and retention of the Bobath concept among undergraduate physiotherapy students. The Bobath approach, widely used in neurorehabilitation, requires learners to integrate postural control principles, movement facilitation techniques, and sensorimotor strategies-skills traditionally taught through face-to-face lectures and hands-on demonstrations. Given the increasing integration of digital technologies in health professions education, immersive VR may offer an alternative through interactive, high-fidelity, and repeatable learning experiences.

Students will be randomized to receive either a standardized face-to-face instructional session or an immersive 360° VR-based session of equivalent duration and content. Both groups will be exposed to theoretical explanations and practical demonstrations focusing on trunk control strategies, alignment principles, and facilitation techniques. Practical components in both groups will be reinforced through structured small-group practice following the instructional session.

To ensure methodological rigor, two independent evaluators blinded to group allocation will assess student performance through a multiple-choice knowledge test and a three-station Objective Structured Clinical Examination (OSCE), administered two days after training and again two weeks later to evaluate retention. Inter-rater reliability will be calculated to ensure consistency of scoring across evaluators.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Single (Outcomes Assessor)

Masking Description

This study used a single-blind design in which outcome assessors were blinded to group allocation. Participants, care providers, and investigators were not blinded due to the nature of the educational intervention."

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Third-year undergraduate physiotherapy students.
  • First-time enrollment in the Neurophysiological Approaches II course.
  • No prior training or formal exposure to the Bobath concept.
  • System Usability Scale (SUS) score classified as A+ (96-100 percentile). -Ability to participate in VR or face-to-face instruction as assigned.- Voluntary participation with provision of written informed consent.-

Exclusion Criteria

  • History of medical conditions contraindicating VR use (e.g., vestibular disorders, migraine, epilepsy).
  • Prior experience, certification, or coursework related to the Bobath concept.
  • Failure to provide informed consent.
  • Any condition that may limit safe participation in the educational session or assessments.

Outcomes

Primary Outcomes

Practical Performance Score (OSCE)

Time Frame: Post-test at 2 days and retention test at 2 weeks after the intervention

Practical skill performance is evaluated using a three-station Objective Structured Clinical Examination (OSCE) assessing Bobath-based postural control strategies. Each station uses a standardized 3-point checklist (0 = not performed, 1 = partially performed, 2 = correctly performed). The combined station scores are converted to a 0-100 scale. Score Range: 0-100 Direction: Higher scores indicate better practical performance. All assessments are video-recorded and independently scored by two blinded evaluators using the same scoring rubric. This metric evaluates both immediate skill acquisition and subsequent retention.

Theoretical Knowledge Score

Time Frame: Post-test at 2 days and retention test at 2 weeks after the intervention

Description: The theoretical outcome measure assesses students' understanding of Bobath-based postural control strategies using a 10-item multiple-choice examination. Each correct response is awarded 1 point. Raw scores (0-10) are converted to a 0-100 scale. Score Range: 0-100 Direction: Higher scores indicate better theoretical knowledge. The same standardized test is administered at both assessment points to evaluate learning and retention under the two instructional modalities.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Kocaeli Sağlık ve Teknoloji Üniversitesi
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sena Çınarlı

Asisstant Professor

Kocaeli Sağlık ve Teknoloji Üniversitesi

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
VR Goggles-Supported Virtual Reality Model in Midwifery Basic Clinical Skills Training
NCT07260929University of Gaziantep128
Active, not recruiting
Phase 1
A study to assess the efficacy and safety of Sodium Zirconium Cyclosilicate (SZC) for the Management of High Potassium in Patients with Symptomatic Heart Failure with Reduced Ejection Fraction and Receiving SpironolactoneHyperkalemia in Patients with Symptomatic Heart Failure.MedDRA version: 21.1Level: PTClassification code 10020646Term: HyperkalaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2020-003312-27-HUAstraZeneca AB400
Active, not recruiting
Phase 1
A study to assess the efficacy and safety of Sodium Zirconium Cyclosilicate (SZC) for the Management of High Potassium in Patients with Symptomatic Heart Failure with Reduced Ejection Fraction and Receiving SpironolactoneHyperkalemia in Patients with Symptomatic Heart FailureMedDRA version: 21.1Level: PTClassification code 10020646Term: HyperkalaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2020-003312-27-ESAstraZeneca AB400
Active, not recruiting
Not Applicable
Phase IV, Double-blind, Multi-center, Randomized, Cross-over Study to Compare 0.10 mmol/kg of MultiHance R with 0.10 mmol/kg of Omniscan R in Magnetic Resonance Imaging MRI of the Brain - Crossover Comparison of MultiHance R and Omniscan R in Brain Tumorspatients sent to the sites with a request for assessment/diagnoses of certain/suspected brain neoplasmsMedDRA version: 6.1Level: PTClassification code 10029816
EUCTR2006-001680-33-ITBRACCO IMAGING114
Active, not recruiting
Not Applicable
Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with Higher Copegus Doses in Treatment-naïve Patients with Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Baseline Body Weight Greater than or Equal to 85 kggenotype 1 chronic hepatitis C infection of high viral titer and baseline body weight greater than or equal to 85 kgMedDRA version: 8.1Level: LLTClassification code 10008912Term: Chronic hepatitis C
EUCTR2005-005507-41-HUF. Hoffmann-La Roche Ltd1,140